Covid-19 research: Inhaled multiple sclerosis drug 'speeds recovery'

Just 13 per cent of Covid-19 hospital patients given SNG001 fell ill enough to need intensive care, compared to 22 per cent of those on a placebo, the Southampton University study found.

from Health News | Mail Online https://ift.tt/3ko2N35

Comentarii

Postări populare de pe acest blog

Telehealth hubs offer care options for people living on the edge the virtual world

Overuse on cattle feedlots is a key factor in antibiotic resistance, report says

Bringing Your Ballpark Food Favorites Home